1
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Tyrosine Phosphorylations In Vivo Associated with v-fms Transformation

, , &
Pages 176-185 | Received 28 Jul 1987, Accepted 09 Oct 1987, Published online: 31 Mar 2023

Literature Cited

  • Anderson, S. J., M. Furth, S. K. Ruscetti, and C. J. Sherr. 1982. Monoclonal antibodies to the transformation-specific glycoprotein encoded by the feline retroviral oncogene v-fms. J. Virol. 44:696-702.
  • Anderson, S. J., M. A. Gonda, C. W. Rettenmier, and C. J. Sherr. 1984. Subcellular localization of glycoprotein encoded by the viral oncogene v-fms. J. Virol. 51:730-741.
  • Barbacid, M., and A. V. Lauver. 1981. Gene products of McDonough feline sarcoma virus have an in vitro-associated protein kinase that phosphorylates tyrosine residues: lack of detection of this enzymatic activity in vivo. J. Virol. 40:812-821.
  • Barbacid, M., A. V. Lauver, and S. G. Devare. 1980. Biochemical and immunological characterization of polyproteins coded for by the McDonough, Gardner-Amstein, and Synder-Theilen strains of feline sarcoma virus. J. Virol. 33:196-207.
  • Bishop, J. M. 1985. Viral oncogenes. Cell 42:23-38.
  • Bishop, J. M. 1987. The molecular genetics of cancer. Science 235:305-311.
  • Browning, P. J., H. F. Bunn, A. Cline, M. Shuman, and A. W. Nienhuis. 1986. “Replacement” of COOH-terminal truncation of v-fms with c-fms sequences markedly reduces transformation potential. Proc. Natl. Acad. Sci. USA 83:7800-7804.
  • Cartwright, C. A., W. Eckhart, S. Simon, and P. L. Kaplan. 1987. Cell transformation by pp60c-src mutated in the carboxyterminal regulatory domain. Cell 49:83-91.
  • Cooper, J. A., and T. Hunter. 1983. Regulation of cell growth and transformation by tyrosine-specific protein kinases: the search for important cellular substrate proteins. Curr. Top. Microbiol. Immunol. 107:125-161.
  • Coussens, L., C. Van Beveren, L. D. Smith, E. Chen, R. Mitchell, C. M. Isacki, I. M. Verma, and A. Ullrich. 1986. Structural alteration of viral homologue of receptor protooncogene fms at carboxyl terminus. Nature (London) 320:549-552.
  • DeClue, J. E., and G. S. Martin. 1987. Phosphorylation of talin at tyrosine in Rous sarcoma virus-transformed cells. Mol. Cell. Biol. 7:371-378.
  • Donner, L., L. A. Fedele, C. F. Garon, S. J. Anderson, and C. J. Sherr. 1982. McDonough feline sarcoma virus: characterization of the molecularly cloned provirus and its feline oncogene (v-fms). J. Virol. 41:489-500.
  • Fukami, Y., T. Nakamura, A. Nakayama, and T. Kanehisa. 1986. Phosphorylation of tyrosine residues of calmodulin in Rous sarcoma virus-transformed cells. Proc. Natl. Acad. Sci. USA 83:4190-4193.
  • Hampe, A., M. Gobet, C. J. Sherr, and F. Galbert. 1984. Nucleotide sequence of the feline retroviral oncogene v-fms shows unexpected homology with oncogenes encoding tyrosinespecific protein kinases. Proc. Natl. Acad. Sci. USA 81:85-89.
  • Heldin, C. H., and B. Westermark. 1984. Growth factors: mechanism of action and relation to oncogenes. Cell 37:9-20.
  • Huang, K.-S., B. P. Wallner, R. J. Mattaliano, R. Tizard, C. Burne, A. Frey, C. Hession, P. McGray, L. K. Sinclair, E. P. Chow, J. L. Browning, K. L. Ramachandran, J. Tang, J. E. Smart, and R. B. Pepinsky. 1986. Two human 35 kd inhibitors of phospholipase A2 are related to substrates of pp60v-src and of the epidermal growth factor receptor/kinase. Cell 46:191-199.
  • Hunter, T. 1987. A tail of two src’s: mutatis mutandis. Cell 49:1-4.
  • Hunter, T., and J. A. Cooper. 1985. Protein-tyrosine kinases. Annu. Rev. Biochem. 54:897-930.
  • Kadowaki, T., S. Koyasu, E. Nishida, K. Tobe, T. Izumi, F. Tadadu, H. Sakai, I. Yahara, and M. Kasuga. 1987. Tyrosine phosphorylation of common and specific sets of cellular proteins rapidly induced by insulin, insulin-like growth factor I, and epidermal growth factor in an intact cell. J. Biol. Chem. 262:7342-7350.
  • Kmiecik, T. E., and D. Shalloway. 1987. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell 49:65-73.
  • Korman, A. J., J. D. Frantz, J. L. Strominger, and R. C. Mulligan. 1987. Expression of human class II major histocompatibility complex antigens using retrovirus vectors. Proc. Natl. Acad. Sci. USA 84:2150-2154.
  • McDonough, S. K., S. Larsen, R. S. Brodey, N. D. Stock, and W. D. Hardy, Jr. 1971. A transmissible feline fibrosarcoma of viral orgin. Cancer Res. 31:953-956.
  • Moria, A. O., and J. Y. J. Wang. 1986. Protein tyrosine phosphorylation in the cell cycle of BALB/c 3T3 fibroblasts. Proc. Natl. Acad. Sci. USA 83:8191-8195.
  • Nichols, E. J., R. Manger, S. Hakomori, A. Herscovics, and L. R. Rohrschneider. 1985. Transformation by the v-fms oncogene product: role of glycosylational processing and cell surface expression. Mol. Cell. Biol. 5:3467-3475.
  • Piwnica-Worms, H., K. B. Saunders, T. M. Roberts, A. E. Smith, and S. H. Cheng. 1987. Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src. Cell 49:75-82.
  • Rettenmier, C. W., M. F. Roussel, C. O. Quinn, G. R. Kitchingman, A. T. Look, and C. J. Sherr. 1985. Transmembrane orientation of glycoprotein encoded by the v-fms oncogene. Cell 40:971-981.
  • Reynolds, F. H., Jr., W. J. M. Van de Ven, J. Blomberg, and J. R. Stephenson. 1981. Differences in mechanisms of transformation by independent feline sarcoma virus isolates. J. Virol. 38:1084-1089.
  • Roussel, M. F., T. J. Dull, C. W. Rettenmier, P. Ralph, A. Ullrich, and C. J. Sherr. 1987. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor). Nature (London) 325:549-552.
  • Roussel, M. F., C. W. Rettenmier, A. T. Look, and C. J. Sherr. 1984. Cell surface expression of v-fms-coded glycoproteins is required for transformation. Mol. Cell. Biol. 4:1999-2009.
  • Ruscetti, S. K., L. P. Turek, and C. J. Sherr. 1980. Three independent isolates of feline sarcoma virus code for three distinct gag-x polyproteins. J. Virol. 35:259-264.
  • Sacca, R., E. R. Stanley, C. J. Sherr, and C. W. Rettenmier. 1986. Specific binding of the mononuclear phagocyte colonystimulating factor CSF-1 to the product of the v-fms oncogene. Proc. Natl. Acad. Sci. USA 83:3331-3335.
  • Sefton, B. M. 1986. The viral tyrosine protein kinases. Curr. Top. Microbiol. Immunol. 123:40-72.
  • Sherr, C. J., C. W. Rettenmier, R. Sacca, M. F. Roussel, A. T. Look, and E. R. Stanley. 1985. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 41:665-676.
  • Southern, P. J., and P. Berg. 1982. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1:327-341.
  • Tamura, T., E. Simon, H. Neimann, G. T. Snoek, and H. Bauer. 1986. gp140v-fms molecules expressed at the surface of cells transformed by the McDonough strain of feline sarcoma virus are phosphorylated in tyrosine and serine. Mol. Cell. Biol. 6:4745-4748.
  • Van de Ven, W. J. M., F. H. Reynolds, Jr., R. P. Nalewaik, and J. R. Stephenson. 1980. Characterization of a 170,000-dalton polyprotein encoded by the McDonough strain of feline sarcoma virus. J. Virol. 35:165-175.
  • White, M. F., and C. R. Kahn. 1986. The insulin receptor and tyrosine phosphorylation, p. 247-310. In P. D. Boyer and E. F. Krebs (ed.), The enzymes, vol. 17. Academic Press, Inc., Orlando, Fla.
  • White, M. F., R. Maron, and C. R. Kahn. 1985. Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells. Nature (London) 318:183-186.
  • Wigler, M., A. Pellicer, S. Silverstein, and R. Axel. 1978. Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor. Cell 14:723-731.
  • Woolford, J., V. Rothwell, and L. Rohrschneider. 1985. Characterization of the human c-fms gene product and its expression in cells of the monocyte-macrophage lineage. Mol. Cell. Biol. 5:3458-3466.
  • Yarden, Y., J. A. Escobedo, W.-J. Kuang, T. L. Yang-Feng, T. O. Daniel, P. M. Tremble, E. Y. Chen, M. E. Ando, R. N. Harkins, U. Francke, V. A. Fried, A. Ullrich, and L. T. Williams. 1986. Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature (London) 323:226-232.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.